Cord blood albumin as predictor of neonatal hyperbilirubinemia


  • Chandan M. V. Department of Pediatrics, Father Muller Medical College, Mangaluru, Karnataka, India
  • Praveen B. K. Department of Pediatrics, Father Muller Medical College, Mangaluru, Karnataka, India



Albumin, Cord blood, Neonatal hyperbilirubinemia, Transcutaneous bilirubin


Background: Measuring the Cord blood Albumin level and predicting neonatal hyperbilirubinemia.

Methods: Prospective study was performed on 160 healthy term neonates. Relevant maternal history was collected. Cord blood was collected from the healthy term neonates at birth and cord serum albumin measured. Neonate was assessed for jaundice every day using transcutaneous bilirubinometer. Total Serum Bilirubin (TSB) was assessed if the Transcutaneous Bilirubin (TCB) values were found high and treated according to NICU protocol.

Results: Study cohort was grouped as Group A, Group B and Group C based on Cord Serum Albumin (CSA) level ≤3.3 g/dl, 3.3-3.8 g/dl and ≥3.8 g/d respectively. Statistical analysis was done for correlation of CSA with Neonatal Hyperbilirubinemia (NH). It showed that cord serum albumin level ≤3.8 g/dl is critical, as it was seen in 9.1% of neonates who developed neonatal hyperbilirubinemia (p value-0.032).

Conclusions: There is a correlation between cord serum albumin level and neonatal hyperbilirubinemia. Cord serum albumin level of ≤3.8 g/dl is a risk indicator in predicting the development of neonatal hyperbilirubinemia.


Cloherty J, C Eichenwald E, R stark A. In: Williams L, eds. Manual of neonatal care. 8th ed. a wolter kluver business; 2015:337.

Piazza AJ, Stoll BJ. Jaundice and Hyperbilirubinemia in the Newborn. In Kliegman RM, Behrman RE, Jenson HB, Stanton BF eds. Nelson textbook of Pediatrics: 18th ed. New Delhi; Saunders Elsevier; 2008;2:756-766.

Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatr. 1999 Jan 1;103(1):6-14.

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatr. 2004 Jul;114(1):297.

Mishra S, Chawla D, Agarwal R, Deorari AK, Paul VK. Transcutaneous bilirubin levels in healthy term and late preterm Indian neonates. Ind J Pediatr. 2010 Jan 1;77(1):45-50.

Mahajan G, Kaushal RK, Sankhyan N, Sharma RL, Nakra M. Transcutaneous bilirubinometer in assessment of neonatal jaundice in northern India. Ind Pediatr. 2005 Jan 1;42(1):41-5.

Woodgate P, Jardine LA. Neonatal jaundice. BMJ Clin Evid. 2011;2011:0319.

Chauhan HR, Parekh AN, Gohil JR. Cord Blood Albumin as A Predictor of Neonatal Hyperbilirubinemia: A Prospective Open Label Study. National J Integ Res Med. 2017 Sep 1;8(5).

Reshad M, Ravichander B, Raghuraman TS. A study of cord blood albumin as a predictor of significant neonatal hyperbilirubinemia in term and preterm neonates. Int J Res Med Sci. 2016;4(3):887-90.

Sahu S, Abraham R, John J, Mathew MA, Res M. Cord blood albumin as a predictor of neonatal jaundice. Int J Biol Med Res. 2011 Jan 31;2(1):436-8.






Original Research Articles